Precision Therapeutics Inc (AIPT.OQ)
26 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Precision Therapeutics Signs Letter Of Intent To Purchase Remainder Of Helomics Corporation Shares
- BRIEF-Precision Therapeutics Q4 Loss Per Share $0.43
- BRIEF-Precision Therapeutics Announces Record Streamway System Sales In The First Three Months Of 2018
- BRIEF-Precision Therapeutics Unit Announces License Agreement With Cellbridge Inc
- BRIEF-Precision Therapeutics Subsidiary, Tumorgenesis, Announces License Agreement With 48Hour Discovery